Eloralintide 10mg
Eloralintide (LY3841136) · 10mg vial
Research use only · Not for human or veterinary consumption · Not for self-administration
Eloralintide is an investigational, long-acting peptide designed to selectively activate amylin receptors. Amylin is a pancreatic hormone co-secreted with insulin that is involved in satiety, gastric emptying and glucose regulation.
Pricing · per vial
Mix & match any vials — 2–4 −10%, 5+ −15%In transit · ETA 20 Nov
How it works
Rather than acting on GLP-1 or GIP receptors, eloralintide targets the amylin pathway, which signals fullness and slows gastric emptying. Its extended half-life supports a once-weekly research schedule.
Research context
A 48-week phase 2 trial published in The Lancet evaluated once-weekly doses from 1mg to 9mg in adults with obesity or overweight. It remains investigational and is not approved by any regulator.
Vial contents & handling
- 10mg eloralintide
- Single lyophilised vial
Quality & sourcing. Sourced from established manufacturers who test using HPLC analysis. COA available on request — ask us on WhatsApp ↗
Storage: keep unopened lyophilised vials in a cool, dark place. Once reconstituted, store in the fridge at 2–8°C and use within 2 months.
Research reference dosage
10mg vial · 3ml water · 3.33mg/ml| Level | Amount | U100 units | Frequency |
|---|---|---|---|
| Beginner | 1mg | 30 units | 1× weekly · any time |
| Intermediate | 2.5mg | 75 units | 1× weekly · any time |
| Advanced | 5mg | 150 units | 1× weekly · any time |
Fixed 3ml · U100 device (1 unit = 0.01ml). Long-acting, once-weekly profile; titrate gradually. Advanced (150 units) exceeds one 100-unit syringe fill. Research reference only.